Jankovic, J.; Carruthers, J.; Naumann, M.; Ogilvie, P.; Boodhoo, T.; Attar, M.; Gupta, S.; Singh, R.; Soliman, J.; Yushmanova, I.;
et al. Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX®) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis. Toxins 2023, 15, 342.
https://doi.org/10.3390/toxins15050342
AMA Style
Jankovic J, Carruthers J, Naumann M, Ogilvie P, Boodhoo T, Attar M, Gupta S, Singh R, Soliman J, Yushmanova I,
et al. Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX®) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis. Toxins. 2023; 15(5):342.
https://doi.org/10.3390/toxins15050342
Chicago/Turabian Style
Jankovic, Joseph, Jean Carruthers, Markus Naumann, Patricia Ogilvie, Terry Boodhoo, Mayssa Attar, Swati Gupta, Ritu Singh, John Soliman, Irina Yushmanova,
and et al. 2023. "Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX®) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis" Toxins 15, no. 5: 342.
https://doi.org/10.3390/toxins15050342
APA Style
Jankovic, J., Carruthers, J., Naumann, M., Ogilvie, P., Boodhoo, T., Attar, M., Gupta, S., Singh, R., Soliman, J., Yushmanova, I., Brin, M. F., & Shen, J.
(2023). Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX®) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis. Toxins, 15(5), 342.
https://doi.org/10.3390/toxins15050342